Prothena Corp PLC (FRA:0PT)
€ 14.9 -0.3 (-1.97%) Market Cap: 760.23 Mil Enterprise Value: 250.23 Mil PE Ratio: 0 PB Ratio: 1.41 GF Score: 74/100

Prothena Corporation PLC to Review Oral Presentations from AD/PD 2021 Transcript

Mar 11, 2021 / 09:30PM GMT
Release Date Price: €19.1 (+6.70%)

Mar 11, 2021 / 09:30PM GMT
Presentations from AD/PD 2021
Mar 11, 2021 / 09:30PM GMT

=====================
Corporate Participants
=====================
* Ellen Rose
Prothena Corporation plc - Head of Communications
* Gene G. Kinney
Prothena Corporation plc - President, CEO & Director
* Philip Dolan
* Radhika Tripuraneni
Prothena Corporation plc - Chief Development Officer
* Tran B. Nguyen
Prothena Corporation plc - CFO & COO
* Wagner M. Zago
Prothena Corporation plc - Chief Scientific Officer

=====================
Conference Call Participants
=====================
* Charles Cliff Duncan
Cantor Fitzgerald & Co., Research Division - Senior Analyst
* Jay Olson
Oppenheimer & Co. Inc., Research Division - Executive Director & Senior Analyst
* Kennen B. MacKay
RBC Capital Markets, Research Division - MD & Co-Head of US Biotechnology Research
* Michael Jonathan Yee
Jefferies LLC, Research Division - Equity Analyst
* Robert Cummins Hazlett

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot